Transfus Med Rev. 2012 Jan 12;

Authors: Verduin EP, Brand A, Schonewille H

Abstract
Large scale red blood cell (RBC) antigen genotyping of donors is currently well developed. There is scarce information, however, to select patients who might benefit from preemptive extended RBC antigen-matched transfusions. Female sex has been proposed as a risk factor for RBC alloimmunization after transfusion. To asses whether females respond differently to RBC alloantigens compared with males, we conducted a literature review on RBC alloimmunization. Clinical studies on RBC alloimmunization incidence were searched for in databases from 1950 through 2011. Studies were included when data were available to calculate the female-to-male risk ratio for alloimmunization. Based on the reported age, adult patients (>18 years) were distinguished from pediatric patients (≤18 years), and articles were analyzed according to disease categories. Thirty articles fulfilled the inclusion criteria. The Mantel-Haenszel risk ratio estimate of combined adult studies showed that women with sickle cell disease had an increased relative risk (27%) on RBC alloantibodies compared with men. Other groups showed equal alloimmunization risk in women and men. Women slightly more often than men possess RBC antibodies. This is likely explained by more exposure to immunizing events through pregnancy and/or transfusions in females with sickle cell disease. The results support the current policy implemented in many countries for Rhesus/Kell matching in patients with a hemoglobinopathy irrespective of sex. Thus, based solely on sex difference, the results do not justify recommending additional matching for women, besides preemptive K and c antigen matching for women during the (pre-) fertile age, as already applied in many European countries for the prevention of fetal morbidity.

PMID: 22244869 [PubMed - as supplied by publisher]

viagra online

In recent years, concern about the effects of BPA, particularly on fetuses and young children, have been growing. Animal studies have shown that BPA can cause reproductive abnormalities in both males and females by disrupting the endocrine system, according to background information in the study. Lipid profile: High levels of LDL cholesterol (bad cholesterol) in the blood promotes atherosclerosis. Main article: Penile prosthesis The men handling BPA were four times as likely to suffer from erectile dysfunction and seven times as likely to have difficulty with ejaculation, said De-Kun Li, a scientist at the Kaiser Foundation Research Institute, which conducted the study with funds from the National Institute for Occupational Safety and Health. The cardiac effects associated with sildenafil have been studied extensively. Sildenafil is absolutely contraindicated in patients taking nitrates such as nitroglycerin or isosorbide. This is because sildenafil, like the other PDE-5 inhibitor medications, can potentiate the vasodilatory effects of the nitrate-based medication, resulting in an exaggerated vasodilatory effect that is potentially dangerous. Patients with serious cardiac disease, with exertional angina, or taking multiple antihypertensive medications are advised to seek the advice of a cardiologist before beginning therapy with sildenafil. A number of studies examining the cardiac effects of sildenafil have conclusively shown that no adverse consequences exist under normal circumstances. The history should include the frequency and duration of symptoms, the presence or absence of morning erections and the quality of the relationship with the sexual partner. The sudden onset of erectile dysfunction in association with normal morning erections or a poor relationship suggests psychogenic impotence.4 No reports on long-term use Dr. Peter Chun-Yip Tong who led the study said: "The development of erectile dysfunction should alert both patients and healthcare providers to the future risk of coronary heart disease." What are my “numbers”? Work with your doctor to measure and control: Myth #4: Alcohol makes you more relaxed and can increase your ability to maintain an erection. Submitted: 23 May 2006 The researchers focused on the paraventricular nucleus (PVN) of the hypothalamus, located in the brain, an integration center between the central and peripheral nervous systems. The site is involved in numerous functions, including erectile function and sexual behavior, and is a primary site within the forebrain that has been implicated in penile erection. The investigators also examined central nitric oxide (NO within the PVN) which plays an important role in the neurotransmission of normal penile erection. cialis online Have you been able to achieve and maintain erections in the past? By Serena Gordon The laboratory investigation depends on information gathered during the interview. Laboratory testing is necessary for most patients, although some may not require any laboratory work. Several other, more invasive options exist for patients who do not respond to PDE-5 inhibitor therapy or in whom it is contraindicated. Alprostadil (prostaglandin E1) causes smooth-muscle relaxation and subsequent vasodilation by acting on adenylate cyclase to increase the intracellular cyclic adenosine monophosphate (cAMP) concentration. Prostaglandin E1 may be administered intraurethrally, where it is absorbed and transported throughout the erectile bodies. The reported efficacy of intraurethral alprostadil therapy is variable. Padma-Nathan and colleagues59 reported a response rate of 65.9%. Fulgham and associates60 noted improvement in 30% of patients; however, this study has been criticized for inadequate dose titration.61 The most common side effect of intraurethral alprostadil therapy is local penile pain caused by drug-mediated sensitization of nerve fibres.60 Missed Signals